Neonatal Abstinence Syndrome (NAS)

Similar documents
Neonatal Abstinence Syndrome

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

MOMS Project Panel Overview

Opioid use in pregnancy and Neonatal Abstinence Syndrome

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

Neonatal Abstinence: The epidemic Its Impact on All of Us

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE

Outcomes of Infants with Neonatal Abstinence Syndrome

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Neonatal Abstinence Syndrome:

Maternal and Child Health, Substance Abuse Ohio Department of Health, Bureau of Maternal Child and Family Health

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

Chronic Pain in Women and its Relationship to Opioid Addiction

Non-Pharmacologic Treatment for Infants with Neonatal Abstinence Syndrome (NAS)

Opioid Abuse Treatment in Pregnancy

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Ohio Perinatal Quality Collaborative

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

TITLE V MATERNAL & CHILD HEALTH 5-YEAR STATE ACTION PLAN

Neonatal Abstinence Syndrome:

Methadone and Pregnancy

Opioids in Pregnancy. Beyond to Baby GENERAL INFO

Mental and Behavioral Health

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

Multidisciplinary Management of the Opioid Crisis To Optimize Perinatal Outcome in a Rural Women s Clinic Population

Brief History of Methadone Maintenance Treatment

Medication for the Treatment of Addiction (MAT)

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine

NEONATAL ABSTINENCE SYNDROME. NAS Kickoff 11/8/18

Opiate Abuse and the Growing Impact on Maternal and Child Health in West Virginia. Overview

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Neonatal abstinence syndrome

Neonatal Abstinence Syndrome: Focus on Prevention and Role of Collaboratives

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome

Medication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers

The Impact of Addiction on Infant Mortality

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center

Addressing Substance Abuse To Improve Well-Being in Child Welfare Systems Current Trends, Continuing Challenges

The Opioid-Exposed Woman

Marijuana During Pregnancy: An Overview

Clinical Management of Neonatal Abstinence Syndrome. Tricia L. Romesberg, DNP, MSN, ARNP, CNNP

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Emerging Populations: Challenges for the Early Childhood System. Presented by Maureen Greer

IN-PATIENT PEDIATRIC REHABILITATION

Running head: NEONATAL ABSTINENCE SYNDROME 1

Perinatal, Neonatal, Pediatric Conference

EAT, SLEEP, CONSOLE The Yale Method of assessment and treatment of neonates during withdrawal from opiates

... Health. Department of. Prenatal Drug Exposure and Neonatal Abstinence Syndrome in Northeast TN. Overview and Regional Snapshot

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

10 INDEX Acknowledgements, i

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy

Safe Babies Foster Parent Training Program

The Role of the Health Care Team in Solving the Opioid Epidemic. October 31, Panelist

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

Substance-Exposed Newborn

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.

Testimony of Debra L. Bogen, MD, F AAP, F ABM

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

ASTHO President s Challenge 15 x 15: Reduce Prescription Drug

Opioids and Marijuana. Bertha K Madras, PhD Professor of Psychobiology Department of Psychiatry Harvard Medical School

Supersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

EI Leadership April 24, 2018

SERVING SUBSTANCE EXPOSED NEWBORNS IN HARFORD COUNTY

The Impact of Neonatal Abstinence Syndrome: The View from a Rural Kentucky Hospital

HELPING OUR MOST VULNERABLE POPULATIONS IMPACTED BY THE OPIOID CRISIS: PREGNANT WOMEN, THEIR INFANTS, AND THOSE RECEIVING CHILD WELFARE SERVICES

Understanding Prenatal Drug Exposure

Substance-Exposed Newborns

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

Neonatal Abstinence Syndrome In Kentucky. Annual Report. From the Public Health Neonatal Abstinence Syndrome Reporting Registry

Why NAS? Proposed Program

Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment

Substance-Exposed Newborns

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

Neonatal Abstinence Syndrome

Advancing the Care of Pregnant and Parenting Women with Opioid Use Disorder and their Infants: A Foundation for Clinical Guidance

Marijuana Use During Pregnancy and Breastfeeding Findings Summary

REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN. Lyn Raible, M.D., Ph.D. CMO, Aegis

Prenatal Substance Abuse: Improving Outcomes

Pharmacist s Role In Pain Management. Katrina Lynn, Pharm D PSHP Annual Assembly: October 12, 2017

Perinatal Opioid Use: Understanding and Aligning Response between Systems

THE OPIOID CRISIS 9/19/2018 DEFINING THE CRISIS DEFINING THE CRISIS NUMBER OF OPIOID-RELATED OVERDOSE DEATHS IN ALABAMA

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH

Child Welfare and MOMS: Building Partnerships to Improve Care

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a

A New approach to NAS: home in 6 days

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Effects of Prenatal Illicit Drug. Use on Infant and Child

Maine s Response to the Opiate Crisis. Christopher Pezzullo, DO State Health Officer Maine DHHS Maine CDC November 12, 2016

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING

Drugs cross the placenta producing a new set of pharmacokinetics.

Strategies to Manage The Opioid Crisis

Transcription:

Neonatal Abstinence Syndrome (NAS) Jodi Jackson, MD Neonatologist Children's Mercy Hospital Associate Professor of Pediatrics University of Missouri-Kansas City School of Medicine Medical director NICU Shawnee Mission Medical Center The Children's Mercy Hospital, 2016

Populations of Abuse Illegal drugs Prescription drugs Populations merge People can illegally acquire prescription drugs Start with prescription drugs and devolve to illegal drugs Start with illegal drugs, and evolve to programs using prescription drugs Methadone Subutex/Suboxone (Buprenorphine)

What is NAS? Infants born to mothers taking some medications during pregnancy may develop symptoms after delivery upon cessation of exposure These symptoms (neurological, gastrointestinal, respiratory) are a complex known as Neonatal Abstinence Syndrome (NAS) Neonatal withdrawal symptoms have been noted to occur following prenatal exposure to several drug classes Opioids Benzodiazepines Mood-stabilizing medications Selective serotonin reuptake inhibitors Nicotine Kraft, W. Van Den Anker, J. (2012). Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome, Pediatr Clni N Am 59, 1147-1165

Is NAS a Real Problem? Over the last decade, there has been increasing public health, medical, and political attention paid to the parallel rise in 2 trends 1) Increased prevalence of prescription opioid abuse 2) Increased incidence of NAS Increase in the prevalence of NAS; varies by study and by state 1.2-5.9 per 1000 hospital births; 2000-2012 Patick, SW et al.j Perinatol 2015; 35:350-355 7-27 per 1000 NICU admissions; 2004-2013 Tolia VN et al. N Engl J Med 2015;372:2118-2126 addresses a study of 299 clinical sites (making up 33 states) SMMC; 16 /1000 NICU admits, 2/1000 hospital admits; 80% up over 5 years National Average LOS for NAS requiring tx ~ 19 days

Annualized Neonatal Intensive Care Unit (NICU) Admission Rates for Neonatal Abstinence Syndrome and Median Length of Stay, According to Year. I bars in Panel B represent interquartile ranges Tolia VN et al. N Engl J Med 2015;372:2118-2126.

Abuse of Prescription Drugs Prescription drugs of abuse Opioids Stimulants Central nervous system (CNS) depressants Factors contributing to severity of prescription drug crisis Drastic increases in the number of prescriptions written Greater social acceptability for using medications Aggressive marketing by pharmaceutical companies

Number of ER visit/year Gregory L. Kirk, MD Psychiatrist addiction news, addiction opinion, and public health RMPC

https://www.drugabuse.gov/about-nida/legislativeactivities/testimony-to-congress/2016/americasaddiction-to-opioids-heroin-prescription-drug-abuse

https://www.drugabuse.gov/about-nida/legislative-activities/testimony-tocongress/2016/americas-addiction-to-opioids-heroin-prescription-drug-abuse

America s Addiction to Opioids: Heroin and Prescription Drug Abuse May 14, 2014; presented by Nora D. Volkow, M.D.; Senate Caucus on International Narcotics Control Relationship between Prescription Opioids & Heroin Abuse The recent trend of a switch from prescription opioids to heroin alerts us to the complex issues surrounding opioid addiction and the intrinsic difficulties in addressing it through any single measure Of particular concern has been the rise in new populations of heroin users, particularly young people.

NEONATAL ABSTINENCE SYNDROME 55 94% of opiate exposed infants will have NAS symptoms 30% avoid treatment with comfort measures 30 to 70% may require pharmacological tx Pharmacological tx goal: symptom relief Weight gain Avoid seizures

How to Support Babies There is wide variation in which babies exposed to medications in utero will have NAS. Many can be treated with Comfort Measures alone, others required treatment with medications. Key Factors in NAS Care Consistent care Comfort Care Consistent Scoring Care giver education is essential, all members of care team

Supporting the Families Supports the Baby Family education during the pregnancy Collaboration between hospital care team and prenatal outpatient OB team prior to delivery is essential Family and provider education regarding non-narcotic treatment of pain before, during and after birth is crucial Support of mothers during pregnancy regarding drug rehab, or just a stable environment can be beneficial to both mom and baby, and may result in the best outcome for both

This Amazing Program via VON

Key Factors in NAS Care NAS Protocol to Guide Consistent Care Nursing Education Family Education Comfort Care Consistent Timing of Scoring Scoring Consistency Consistency in Treatment Education regarding non-narcotic methods of pain relief Family centered, trauma informed programming for women prior to giving birth, continuing in the post partum

SMMC Data Showing the Benefits of the NAS Program Decreased Treatment and NICU Admissions

Maternal and Infant Identification Infant Screening Drug Screen Protocol Based off Risk Factors vs profiling

Maternal Screening

Maternal Screening

Maternal Screening

Maternal Screening Other Screening Tools: Substance Use Risk Profile-Pregnancy Scale Prenatal Risk Overview T-ACE TWEAK WIDUS CDC funding 3 site, 5 screening tool trial

Comfort Cares

26

31

VISION Vermont Oxford Network Launched in 1989 To build a worldwide community of practice dedicated to providing every newborn infant and family with the best possible and ever improving medical care. 33

https://public.vtoxford.org/quality-education/inicq-2015-nas-universal-training/statewide-collaboratives-and-nas-demonstration-projects/

http://www.acog.org/~/media/departments/government%20relations%20and%20o utreach/2014nasstatecollabchart.pdf

A Kansas NAS State Collaborative Would support woman and protect their unborn child With informed health care Knowledgeable state agents Bring Kansas to the National Stage Issue of NAS Perinatal Quality Collaborative First TOP DOWN strategy for full state involvement Dedicates not just money, but shared ownership May help with the final stage of implementation Hospital and State collaboration on development of programs 41

Big Take Home Consistency of Care Education regarding non-narcotic methods of pain relief Family centered, trauma informed programming for women prior to giving birth, continuing in post partum and beyond Need State s Help!! Use this magic window of time to Protect the Unborn child and change the trajectory of the entire family unit Respectful, supporting interactions --Responses may be surprising

Thank You Questions? SMMC NAS Team Betsy Knappen, MSN, APRN (NAS Program Coordinator) Dr. Betsy Wickstrom (Perinatologist) Danielle Renyer, LMSW (NICU Social Worker) Kim Mason, RN, BSN (Discharge Planner) Dr. Julie Weiner (Neonatologist) Carrie Miner, MSN, RN, CCRN (Nursing Program Coordinator/Clinical Specialist) KPQC beginning to work with state and VON to address maternal support state wide